The unceasing circulation of SARS-CoV-2 leads to the continuous emergence of novel viral
sublineages. Here, we isolate and characterize XBB. 1, XBB. 1.5, XBB. 1.9. 1, XBB. 1.16. 1 …

Variant BA. 2.86 and its descendant, JN. 1, of SARS-CoV-2 are rising in incidence across
Europe and globally. We isolated recent JN. 1, BA. 2.86, EG. 5, XBB. 1.5 and earlier variants …

The vaccines currently form part of the national immunisation programmes in many countries
including Denmark. Both vaccines incorporate a monovalent component designed to target …

Vaccination remains an important mitigation tool against COVID-19. We report 1-month
safety and preliminary immunogenicity data from a substudy of an ongoing, open-label …

Understanding the evolution of the B cell response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) variants is fundamental to design the next generation of …

The recent discovery that TMEM106B serves as a receptor mediating ACE2-independent
SARS-CoV-2 entry into cells deserves attention, especially in the background of the frequent …

The emergence of novel Omicron subvariants has raised concerns regarding the efficacy of
immunity induced by prior Omicron subvariants breakthrough infection (BTI) or reinfection …

This article advocates for mobilizing pathogen genomic surveillance to contain and mitigate
health threats from infectious diseases and antimicrobial resistance (AMR), building upon …

Abstract The EG. 5.1 variant of severe acute respiratory syndrome coronavirus‐2 (SARS‐
CoV‐2) has been prevalent since mid‐July 2023 in the United States and China. The variant …

Host immunity is central to the virus's spread dynamics, which is significantly influenced by
vaccination and prior infection experiences. In this work, we analyzed the co‐evolution of …